Obstacles on the Way to the Clinical Visualisation of Beta Cells: Looking for the Aeneas of Molecular Imaging to Navigate Between Scylla and Charybdis

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2012 Feb 24

PMID 22358499

Citations 34

Authors

K Andralojc

M Srinivas

M Brom

L Joosten

I J M de Vries

D L Eizirik

O C Boerman

P Meda

M Gotthardt

Affiliations

Soon will be listed here.

Abstract

For more than a decade, researchers have been trying to develop non-invasive imaging techniques for the in vivo measurement of viable pancreatic beta cells. However, in spite of intense research efforts, only one tracer for positron emission tomography (PET) imaging is currently under clinical evaluation. To many diabetologists it may remain unclear why the imaging world struggles to develop an effective method for non-invasive beta cell imaging (BCI), which could be useful for both research and clinical purposes. Here, we provide a concise overview of the obstacles and challenges encountered on the way to such BCI, in both native and transplanted islets. We discuss the major difficulties posed by the anatomical and cell biological features of pancreatic islets, as well as the chemical and physical limits of the main imaging modalities, with special focus on PET, SPECT and MRI. We conclude by indicating new avenues for future research in the field, based on several remarkable recent results.

Citing Articles

Bibliometric analysis of research on the utilization of nanotechnology in diabetes mellitus and its complications.

Zhang J, He M, Gao G, Sun T Nanomedicine (Lond). 2024; 19(16):1449-1469.

PMID: 39121376 PMC: 11318711. DOI: 10.1080/17435889.2024.2358741.

Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes.

Moon J, Choe H, Lim S J Diabetes Investig. 2024; 15(6):669-683.

PMID: 38676410 PMC: 11143426. DOI: 10.1111/jdi.14221.

Cross-sectional imaging of the pancreas in diabetes.

Virostko J, Tirkes T Abdom Radiol (NY). 2024; 49(6):2116-2124.

PMID: 38557767 PMC: 11213663. DOI: 10.1007/s00261-024-04310-y.

Characterization of a S1PR2 specific C-labeled radiotracer in streptozotocin-induced diabetic murine model.

Jiang H, Huang T, Yu Y, Zhou C, Qiu L, Mai H Nucl Med Biol. 2023; 122-123:108370.

PMID: 37556928 PMC: 10949307. DOI: 10.1016/j.nucmedbio.2023.108370.

New Insights and Potential Therapeutic Interventions in Metabolic Diseases.

Clemente-Suarez V, Martin-Rodriguez A, Redondo-Florez L, Lopez-Mora C, Yanez-Sepulveda R, Tornero-Aguilera J Int J Mol Sci. 2023; 24(13).

PMID: 37445852 PMC: 10342188. DOI: 10.3390/ijms241310672.

References

Breeman W, Bakker W, de Jong M, Hofland L, Kwekkeboom D, Kooij P . Studies on radiolabeled somatostatin analogues in rats and in patients. Q J Nucl Med. 1996; 40(3):209-20. View

Bhargava R, Senior P, Ackerman T, Ryan E, Paty B, Lakey J . Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes. 2004; 53(5):1311-7. DOI: 10.2337/diabetes.53.5.1311. View

Murua A, Portero A, Orive G, Hernandez R, de Castro M, Pedraz J . Cell microencapsulation technology: towards clinical application. J Control Release. 2008; 132(2):76-83. DOI: 10.1016/j.jconrel.2008.08.010. View

Uttenthal L, Blazquez E . Characterization of high-affinity receptors for truncated glucagon-like peptide-1 in rat gastric glands. FEBS Lett. 1990; 262(1):139-41. DOI: 10.1016/0014-5793(90)80173-g. View

Evgenov N, Medarova Z, Dai G, Bonner-Weir S, Moore A . In vivo imaging of islet transplantation. Nat Med. 2005; 12(1):144-8. DOI: 10.1038/nm1316. View

Wangler B, Beck C, Shiue C, Schneider S, Schwanstecher C, Schwanstecher M . Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repaglinide): a potential beta-cell imaging agent. Bioorg Med Chem Lett. 2004; 14(20):5205-9. DOI: 10.1016/j.bmcl.2004.07.059. View

Koblas T, Girman P, Berkova Z, Jirak D, Kriz J, Dovolilova E . Magnetic resonance imaging of intrahepatically transplanted islets using paramagnetic beads. Transplant Proc. 2005; 37(8):3493-5. DOI: 10.1016/j.transproceed.2005.09.142. View

Bernardi H, Fosset M, Lazdunski M . Characterization, purification, and affinity labeling of the brain [3H]glibenclamide-binding protein, a putative neuronal ATP-regulated K+ channel. Proc Natl Acad Sci U S A. 1988; 85(24):9816-20. PMC: 282872. DOI: 10.1073/pnas.85.24.9816. View

Montet X, Funovics M, Montet-Abou K, Weissleder R, Josephson L . Multivalent effects of RGD peptides obtained by nanoparticle display. J Med Chem. 2006; 49(20):6087-93. DOI: 10.1021/jm060515m. View

10.

Krenning E, Kooij P, Pauwels S, Breeman W, Postema P, de Herder W . Somatostatin receptor: scintigraphy and radionuclide therapy. Digestion. 1996; 57 Suppl 1:57-61. DOI: 10.1159/000201398. View

11.

Woods M, Woessner D, Sherry A . Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. Chem Soc Rev. 2006; 35(6):500-11. PMC: 2718840. DOI: 10.1039/b509907m. View

12.

Antkowiak P, Tersey S, Carter J, Vandsburger M, Nadler J, Epstein F . Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging. Am J Physiol Endocrinol Metab. 2009; 296(3):E573-8. PMC: 2660140. DOI: 10.1152/ajpendo.90336.2008. View

13.

Villiger M, Goulley J, Friedrich M, Grapin-Botton A, Meda P, Lasser T . In vivo imaging of murine endocrine islets of Langerhans with extended-focus optical coherence microscopy. Diabetologia. 2009; 52(8):1599-607. DOI: 10.1007/s00125-009-1383-y. View

14.

Saisho Y, Harris P, Butler A, Galasso R, Gurlo T, Rizza R . Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas. J Mol Histol. 2008; 39(5):543-51. PMC: 2566800. DOI: 10.1007/s10735-008-9195-9. View

15.

Gaglia J, Guimaraes A, Harisinghani M, Turvey S, Jackson R, Benoist C . Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest. 2010; 121(1):442-5. PMC: 3007157. DOI: 10.1172/JCI44339. View

16.

Sakata N, Hayes P, Tan A, Chan N, Mace J, Peverini R . MRI assessment of ischemic liver after intraportal islet transplantation. Transplantation. 2009; 87(6):825-30. PMC: 2779521. DOI: 10.1097/TP.0b013e318199c7d2. View

17.

Gainkam L, Huang L, Caveliers V, Keyaerts M, Hernot S, Vaneycken I . Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT. J Nucl Med. 2008; 49(5):788-95. DOI: 10.2967/jnumed.107.048538. View

18.

Sheppard M, Shapiro B, PIMSTONE B, KRONHEIM S, Berelowitz M, Gregory M . Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man. J Clin Endocrinol Metab. 1979; 48(1):50-3. DOI: 10.1210/jcem-48-1-50. View

19.

Barrett T, Brechbiel M, Bernardo M, Choyke P . MRI of tumor angiogenesis. J Magn Reson Imaging. 2007; 26(2):235-49. DOI: 10.1002/jmri.20991. View

20.

Maffei A, Liu Z, Witkowski P, Moschella F, Del Pozzo G, Liu E . Identification of tissue-restricted transcripts in human islets. Endocrinology. 2004; 145(10):4513-21. DOI: 10.1210/en.2004-0691. View